ArticleDiabetes, obesity & metabolism2026
Comparison of cardiovascular outcomes between once-weekly semaglutide and dulaglutide in adults with type 2 diabetes and established atherosclerotic cardiovascular disease in the United States.
Xi Tan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.